title: Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody.
authors.affiliation: Inserm U 25, CNRS UA 122, Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Chatenoud
authors.forename: C
authors.initials: C
authors.lastname: Ferran
authors.forename: C
authors.initials: C
authors.lastname: Legendre
authors.forename: R
authors.initials: R
authors.lastname: Kurrle
authors.forename: H
authors.initials: H
authors.lastname: Kreis
authors.forename: J F
authors.initials: JF
authors.lastname: Bach
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D015166:Monitoring, Immunologic; D016853:Muromonab-CD3; D010641:Phenotype; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell; D014409:Tumor Necrosis Factor-alpha